133 related articles for article (PubMed ID: 17200766)
1. Relatively increased von Willebrand factor activity after off-pump coronary artery bypass graft surgery.
Lo B; Nierich AP; Kalkman CJ; Fijnheer R
Thromb Haemost; 2007 Jan; 97(1):21-6. PubMed ID: 17200766
[TBL] [Abstract][Full Text] [Related]
2. Decreased von Willebrand factor ristocetin cofactor activity and increased ADAMTS13 antigen increase postoperative drainage after coronary artery bypass grafting.
Mazur P; Plicner D; Zdziarska J; Sadowski J; Undas A
Eur J Cardiothorac Surg; 2014 Feb; 45(2):e26-32. PubMed ID: 24351199
[TBL] [Abstract][Full Text] [Related]
3. Development of a Hyperactive Primary Hemostatic System During Off-Pump Lung Transplantation Resulting From an Unbalance Between von Willebrand Factor and Its Cleaving Protease ADAMTS13.
Hugenholtz GC; Ruitenbeek K; Adelmeijer J; Pereboom IT; Meijers JC; van der Bij W; Porte RJ; Erasmus ME; Lisman T
Am J Transplant; 2015 Jul; 15(7):1958-66. PubMed ID: 25846964
[TBL] [Abstract][Full Text] [Related]
4. Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications.
Michiels JJ; van de Velde A; van Vliet HH; van der Planken M; Schroyens W; Berneman Z
Semin Thromb Hemost; 2002 Apr; 28(2):111-32. PubMed ID: 11992235
[TBL] [Abstract][Full Text] [Related]
5. Assessment of the Diagnostic Value of Plasma Levels, Activities, and Their Ratios of von Willebrand Factor and ADAMTS13 in Patients with Cerebral Infarction.
Qu L; Jiang M; Qiu W; Lu S; Zhao Y; Xia L; Ruan C; Zhao Y
Clin Appl Thromb Hemost; 2016 Apr; 22(3):252-9. PubMed ID: 25916953
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of ADAMTS-13 by Doxycycline Reduces von Willebrand Factor Degradation During Supraphysiological Shear Stress: Therapeutic Implications for Left Ventricular Assist Device-Associated Bleeding.
Bartoli CR; Kang J; Restle DJ; Zhang DM; Shabahang C; Acker MA; Atluri P
JACC Heart Fail; 2015 Nov; 3(11):860-9. PubMed ID: 26454844
[TBL] [Abstract][Full Text] [Related]
7. Acquired type 2A von Willebrand syndrome caused by aortic valve disease corrects during valve surgery.
Solomon C; Budde U; Schneppenheim S; Czaja E; Hagl C; Schoechl H; von Depka M; Rahe-Meyer N
Br J Anaesth; 2011 Apr; 106(4):494-500. PubMed ID: 21278152
[TBL] [Abstract][Full Text] [Related]
8. ADAMTS-13 activity in the presence of elevated von Willebrand factor levels as a novel mechanism of residual platelet reactivity in high risk coronary patients on antiplatelet treatment.
Marcucci R; Cesari F; Cinotti S; Paniccia R; Gensini GF; Abbate R; Gori AM
Thromb Res; 2008; 123(1):130-6. PubMed ID: 18603284
[TBL] [Abstract][Full Text] [Related]
9. Antibody-based prevention of von Willebrand factor degradation mediated by circulatory assist devices.
Rauch A; Legendre P; Christophe OD; Goudemand J; van Belle E; Vincentelli A; Denis CV; Susen S; Lenting PJ
Thromb Haemost; 2014 Nov; 112(5):1014-23. PubMed ID: 25030452
[TBL] [Abstract][Full Text] [Related]
10. Changes in von Willebrand factor-cleaving protease (ADAMTS-13) in patients with aortic stenosis undergoing valve replacement or balloon valvuloplasty.
Bander J; Elmariah S; Aledort LM; Dlott J; Stelzer P; Halperin JL; Kini AS; Sharma SK
Thromb Haemost; 2012 Jul; 108(1):86-93. PubMed ID: 22627470
[TBL] [Abstract][Full Text] [Related]
11. von Willebrand factor, von Willebrand factor-cleaving protease, and shear stress.
Perutelli P; Molinari AC
Cardiovasc Hematol Agents Med Chem; 2007 Oct; 5(4):305-10. PubMed ID: 17979694
[TBL] [Abstract][Full Text] [Related]
12. Acquired von Willebrand factor deficiency caused by LVAD is ADAMTS-13 and platelet dependent.
Jilma-Stohlawetz P; Quehenberger P; Schima H; Stoiber M; Knöbl P; Steinlechner B; Felli A; Jilma B
Thromb Res; 2016 Jan; 137():196-201. PubMed ID: 26616301
[TBL] [Abstract][Full Text] [Related]
13. Activation of hemostasis after coronary artery bypass grafting with or without cardiopulmonary bypass.
Lo B; Fijnheer R; Castigliego D; Borst C; Kalkman CJ; Nierich AP
Anesth Analg; 2004 Sep; 99(3):634-640. PubMed ID: 15333385
[TBL] [Abstract][Full Text] [Related]
14. Levels and activities of von Willebrand factor and metalloproteinase with thrombospondin type-1 motif, number 13 in inflammatory bowel diseases.
Cibor D; Owczarek D; Butenas S; Salapa K; Mach T; Undas A
World J Gastroenterol; 2017 Jul; 23(26):4796-4805. PubMed ID: 28765701
[TBL] [Abstract][Full Text] [Related]
15. The role of ADAMT-13 in platelet adhesion in flow: methods for diagnosis of thrombotic thrombocytopenic purpura.
Shenkman B
Pathophysiol Haemost Thromb; 2006; 35(1-2):98-102. PubMed ID: 16855353
[TBL] [Abstract][Full Text] [Related]
16. Disulfide bond reduction of von Willebrand factor by ADAMTS-13.
Yeh HC; Zhou Z; Choi H; Tekeoglu S; May W; Wang C; Turner N; Scheiflinger F; Moake JL; Dong JF
J Thromb Haemost; 2010 Dec; 8(12):2778-88. PubMed ID: 20946172
[TBL] [Abstract][Full Text] [Related]
17. Magnesium maintains endothelial integrity, up-regulates proteolysis of ultra-large von Willebrand factor, and reduces platelet aggregation under flow conditions.
Dong JF; Cruz MA; Aboulfatova K; Martin C; Choi H; Bergeron AL; Martini SR; Kroll MH; Kent TA
Thromb Haemost; 2008 Mar; 99(3):586-93. PubMed ID: 18327408
[TBL] [Abstract][Full Text] [Related]
18. Formation of methionine sulfoxide by peroxynitrite at position 1606 of von Willebrand factor inhibits its cleavage by ADAMTS-13: A new prothrombotic mechanism in diseases associated with oxidative stress.
Lancellotti S; De Filippis V; Pozzi N; Peyvandi F; Palla R; Rocca B; Rutella S; Pitocco D; Mannucci PM; De Cristofaro R
Free Radic Biol Med; 2010 Feb; 48(3):446-56. PubMed ID: 19969076
[TBL] [Abstract][Full Text] [Related]
19. The O-linked glycans of human von Willebrand factor modulate its interaction with ADAMTS-13.
Nowak AA; McKinnon TA; Hughes JM; Chion AC; Laffan MA
J Thromb Haemost; 2014 Jan; 12(1):54-61. PubMed ID: 24406064
[TBL] [Abstract][Full Text] [Related]
20. Changes in ADAMTS13 (von-Willebrand-factor-cleaving protease) activity after induced release of von Willebrand factor during acute systemic inflammation.
Reiter RA; Varadi K; Turecek PL; Jilma B; Knöbl P
Thromb Haemost; 2005 Mar; 93(3):554-8. PubMed ID: 15735809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
